Showing 111 of 111on this page. Filters & sort apply to loaded results; URL updates for sharing.111 of 111 on this page
Volasertib cancer drug molecule (PLK1 inhibitor). Skeletal formula ...
Structure of PLK1 inhibitor BI-2536 and Volasertib | Download ...
Volasertib (BI 6727) | PLK1 Inhibitor | MedChemExpress
Volasertib molecule plk1 inhibitor formula Vector Image
Volasertib (BI 6727) | PLK1 Inhibitor | CAS 755038-65-4 | Selleck Chemicals
Volasertib accumulates cells in G2/M phase and inhibits mitotic ...
Polo-like kinase 1 inhibitors GSK461364 and volasertib selectively ...
The polo-like kinase 1 inhibitor volasertib synergistically increases ...
Polo-like Kinase Inhibitor Volasertib Exhibits Antitumor Activity and ...
Volasertib induces cytotoxicity and alters polo‐like kinase (PLK ...
In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non ...
Volasertib inhibits polo-like kinase 1 (PLK1) signaling and augments ...
Susceptibility to volasertib and baseline expression of polo‐like ...
Volasertib prevents bipolar spindle formation, inducing cell cycle ...
Volasertib supplier | CAS 755038-65-4 | Focus Biomolecules
Efficacy and tolerability of volasertib in xenograft models of human ...
Polo-like kinase inhibitor volasertib marginally enhances the efficacy ...
Volasertib for AML: clinical use and patient consideration | OTT
(A) MyLa cells were treated with volasertib and BRD4 binding to the ...
A phase I study of two dosing schedules of volasertib (BI 6727), an ...
The combined treatment of volasertib and TRAIL induces caspase-mediated ...
Volasertib | C34H50N8O3 | CID 10461508 - PubChem
PLK1 inhibition by volasertib suppresses key transcriptional regulators ...
Volasertib cancer drug molecule (PLK1 inhibitor). 3D rendering. Atoms ...
Volasertib suppresses tumor growth and potentiates the activity of ...
Volasertib Enhances Sensitivity to TRAIL in Renal Carcinoma Caki Cells ...
Volasertib enhances the anti-tumor effect of TMZ. (A) Inhibition rate ...
Volasertib inhibits the growth of HCC cells in vitro. A: Chemical ...
Volasertib Cancer Drug Molecule Photograph by Molekuul/science Photo ...
Growth inhibition upon volasertib treatment is p53‐dependent. (A ...
The effect of volasertib on cell cycle distribution and apoptosis in ...
The two-dimensional structure (2D) of volasertib and its derivatives ...
Volasertib molecule skeletal formula Royalty Free Vector
Full article: Volasertib for AML: clinical use and patient consideration
Volasertib as single agent and in combination with entinostat exert ...
Volasertib - LGM Pharma
Volasertib cancer drug molecule, illustration - Stock Image - F028/9076 ...
The combination of volasertib (10 mg/kg) and radiation (10 Gy ...
Effects of PLK1 inhibition by volasertib and radiation on apoptosis ...
Volasertib (BI-6727) | PLK inhibitor | Probechem Biochemicals
volasertib blocks bipolar spindle formation, inducing cell cycle arrest ...
Volasertib cancer drug molecule, illustration - Stock Image - F028/9075 ...
Volasertib has the potential to prevent migration of NSCLC cells. (A ...
Volasertib induces premature senescence through, at least partially, a ...
Volasertib cancer drug molecule, illustration - Stock Image - F028/9078 ...
Volasertib suppresses entry into prometaphase and leads to prolonged ...
Effects of volasertib on cell proliferation, apoptosis and cell cycle ...
Combined treatment of volasertib with other agents | Download ...
Volasertib causes cell cycle arrest in G2/M after 72 hours treatment ...
Volasertib decreases cells in S phase, accumulates cells in G2/M phase ...
Structures of PLK inhibitors BI 2536 and volasertib, and design of ...
Volasertib, a PLK1 Inhibitor, Can be Used for Solid Tumors Research ...
Chemical and X-ray structure of volasertib. Chemical structure (a) and ...
Vincristine/Volasertib Polymersome Injection Enables High-Efficiency ...
Phase I trial of volasertib, a Polo‐like kinase inhibitor, in Japanese ...
BI6727 (Volasertib) - Potent Plk Inhibitor for Cancer Research | APExBIO
Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase ...
Phase I trial of volasertib, a Polo-like kinase inhibitor, plus ...
Efficacy and Mechanism of Action of Volasertib, a Potent and Selective ...
(PDF) Efficacy and Mechanism of Action of Volasertib, a Potent and ...
US FDA grants breakthrough therapy designation to Boehringer Ingelheim ...
Polo-like kinase inhibition as a therapeutic target in acute myeloid ...
美国APExBIO中文官网 - BI6727 (Volasertib)|Plk inhibitor,highly potent|CAS ...
Identification of volasertibresistant mechanism and evaluation of ...
Table 2 from Efficacy and mechanism of action of volasertib, a potent ...
Table 1 from Efficacy and mechanism of action of volasertib, a potent ...
Polo-like Kinase 1 Inhibitors Demonstrate In Vitro and In Vivo Efficacy ...
ATP-competitive Plk1 inhibitors induce caspase 3-mediated Plk1 cleavage ...
mTORC1 and PLK1 inhibition in adenocarcinoma NSCLC | Oncotarget
Development of Cell Permeable NanoBRET Probes for the Measurement of ...
A phase I dose-escalation study of the polo-like kinase 1 inhibitor ...
PLK Inhibition | PLK Activation | PLK Inhibitor Review
